'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

LISTEN : Biden wanted to isolate the Saudis. Now he has to kiss the ring
25/05/2022
These small Red Sea islands could help normalize Israeli-Saudi relations
25/05/2022
‘It’s a spiritual earthquake’ : When rabbis become sexual abusers
25/05/2022
How Australia’s new leaders really see Israel and the Palestinians
25/05/2022
It's the most beautiful and dangerous road in Israel. Nobody can drive there
25/05/2022
A Pakistani group visited Israel. Then Pakistan erupted
25/05/2022